Differential in vitro metabolism of beta-endorphin in schizophrenia.
Biologically active peptide fragments derived from the proteolytic cleavage of beta-endorphin (beta E) have been shown to be present in the brain. Based on clinical results using some of these fragments in neuropsychiatric disease studies we investigated the in vitro metabolism of beta E by twice-washed membrane homogenates of postmortem putamen from sex and age matched controls versus subjects with a diagnosis of schizophrenia. The present study demonstrates that frozen (-80 degrees C) postmortem human tissues are viable for these studies and that metabolism in control tissue proceeds similarly to fresh tissues. Furthermore, a significant increase in the formation of the putative neuroleptic-like peptide fragment des-enkephalin-gamma-endorphin in postmortem schizophrenic putamen versus controls was shown. A significant decrease in the formation of beta E was also reported. These data suggest that an approach using postmortem human brain is possible in studying beta-endorphin catabolism and is therefore applicable to other neuropeptide systems.
D000328:Adult; D000368:Aged; D004723:Endorphins / Q000378:metabolism*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000378:metabolism; D011699:Putamen / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism*; D018822:alpha-Endorphin; D001615:beta-Endorphin; D018823:gamma-Endorphin
D004723:Endorphins; D010446:Peptide Fragments; D001615:beta-Endorphin; D018822:alpha-Endorphin; D018823:gamma-Endorphin; C033558:des-enkephalin-gamma-endorphin; C044925:beta-endorphin (6-21)